Biological activity of recombinant human myelin basic protein

Area of Science:

• Neuroimmunology
• Protein biochemistry
• Molecular biology

Background:

• Myelin basic protein (MBP) is a key autoantigen in multiple sclerosis.
• Purification of native MBP from CNS tissue can result in degradation products.
• A reliable source of pure, intact MBP is needed for immunological studies.

Purpose of the Study:

• To produce and characterize recombinant human myelin basic protein (r-MBP) in E. coli.
• To assess the biological activity and structural integrity of r-MBP.
• To establish r-MBP as a superior reagent for immunological research.

Main Methods:

• Expression of r-MBP using an inducible vector in Escherichia coli.
• Purification via cation-exchange chromatography and characterization by SDS-PAGE.
• ELISA reactivity with monoclonal antibodies against human MBP.
• Assessment of T cell proliferation and induction/suppression of experimental autoimmune encephalomyelitis (EAE) in mice.

Main Results:

• r-MBP exhibited similar binding affinity and molecular weight (18.5 kDa) to native MBP.
• ELISA confirmed similar conformation and epitope recognition compared to native MBP.
• r-MBP induced T cell proliferation, EAE in SJL mice, and suppressed EAE upon oral administration.
• Novel purification methods ensured r-MBP was free of proteolytic fragments.

Conclusions:

• Recombinant human MBP produced in E. coli is a structurally and functionally equivalent alternative to native MBP.
• The absence of degradation products makes r-MBP a more advantageous reagent.
• Purified r-MBP is a valuable tool for investigating antigen processing, MHC-TCR interactions, and immune tolerance.